Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Genetic Technologies Ltd (NASDAQ:GENE)

2.42
Delayed Data
As of May 27
 +0.03 / +1.26%
Today’s Change
1.62
Today|||52-Week Range
4.48
-9.70%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
AssetsCash9.1M1.6M2.7M14.1M
 
 
 
 
 
Short Term Investment Cash3.9M-7.3M1.0M12.9M
 
 
 
 
 
Cash & Short Term Investments9.1M1.8M2.7M14.1M
 
 
 
 
 
 
ReceivablesReceivables449.0K300.8K1.0M549.5K
 
 
 
 
 
 
InventoriesInventories324.6K195.7K201.0K244.0K
 
 
 
 
 
 
Current AssetsPrepaid Expenses224.9K168.8K190.6K145.0K
 
 
 
 
 
Other Current Assets61.7K2.8K0.000.00
 
 
 
Current Assets10.2M2.4M4.1M15.0M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross6.4M5.7M5.5M2.0M
 
 
 
 
 
Depreciation-5.7M-5.3M-5.1M-1.7M
 
 
 
 
 
Intangible Assets1.5M1.2M1.1M565.7K
 
 
 
 
 
Other Assets1.5M1.2M1.1M565.7K
 
 
 
 
 
Total Assets16.9M7.6M6.4M15.9M
 
 
 
 
 
 
LiabilitiesAccounts Payable341.0K569.5K849.7K397.4K
 
 
 
 
 
Short Term Debt18.2K0.000.0019.2K
 
 
 
Accrued Expenses236.4K343.7K223.8K331.0K
 
 
 
 
 
Other Current Liabilities860.8K983.2K662.7K509.7K
 
 
 
 
 
Other Liabilities2.0M2.3M2.2M1.3M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt0.000.002.4M0.00
 
 
Total Liabilities2.1M2.3M4.6M1.4M
 
 
 
 
 
 
EquityMinority Interest-9.7K-52.2K-8.5K0.00
 
 
 
 
Preferred Stock0.000.000.000.00--
Common Equity14.6M5.2M1.7M14.6M
 
 
 
 
 
Total Shareholder Equity14.6M5.2M1.7M14.6M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding3.1M3.2M4.1M11.4M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.